Search This Blog

Monday, August 5, 2019

Arrowhead Pharmaceuticals EPS beats by $0.09, misses on revenue

Arrowhead Pharmaceuticals (NASDAQ:ARWR): Q3 GAAP EPS of $0.21 beats by $0.09.
Revenue of $42.7M (+5749.3% Y/Y) misses by $11.67M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)